Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

ST. LOUIS , April 15, 2022 /PRNewswire/ -- Centene Corporation's (NYSE: CNC) Board of Directors issued the following statement today: The Centene Board has accepted the resignation of Leslie V. Norwalk, Esq.

CENTENE BOARD ISSUES STATEMENT ON DEPARTURE OF BOARD MEMBER

Neidorff built Centene through Medicaid contracts and strict cost controls. His successor is under pressure to increase margins.

What Centene's Next Era in Managed Care Looks Like

DETROIT , April 4, 2022 /PRNewswire/ -- Meridian Michigan, a provider of government-sponsored health plans, announced today that it has appointed Dr. Kay Judge as its new Chief Medical Officer, effective April 10, 2022.  Dr. Judge brings over two decades of experience from large health systems in Michigan and California.

Meridian Michigan Announces Appointment of New Chief Medical Officer

– Live Audio Webcast of Annual Meeting Available – ST. LOUIS , April 1, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that following the release of its 2022 first quarter financial results on Tuesday, April 26, 2022, the Company will hold its 2022 Annual Meeting of Stockholders at 11:00 a.m.

CENTENE TO HOLD 2022 ANNUAL MEETING FOLLOWING 2022 FIRST QUARTER FINANCIAL RESULTS CONFERENCE CALL

Centene Corp   (NYSE:CNC) stock is down 0.4% to trade $85.29 at last check, just one week removed from a March 21, record high of $88.61.

Why This Healthcare Stock's Pullback May Be Short-Lived

NEW YORK, March 23, 2022 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Jesse Hunter will join the Firm as an Operating Partner in its Healthcare Group. Mr. Hunter is an accomplished executive with extensive experience driving growth and creating value across the healthcare ecosystem.

Jesse Hunter Joins Welsh, Carson, Anderson & Stowe as Healthcare Operating Partner

ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company.

CENTENE APPOINTS SARAH LONDON AS CHIEF EXECUTIVE OFFICER

ST. LOUIS , March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 26, 2022, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2022 FIRST QUARTER FINANCIAL RESULTS CONFERENCE CALL

Banking on a robust portfolio, buyouts and alliances plus contract wins, Centene (CNC) holds prospects to reap benefits for investors.

Why Holding Centene (CNC) in Your Portfolio is a Smart Move

Anthem

Quest Diagnostics

Danaher

PerkinElmer

UnitedHealth Group

West Pharmaceutical Services

When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. The post 7 Healthcare Stocks to Buy for the Long Term appeared first on InvestorPlace.

7 Healthcare Stocks to Buy for the Long Term

ST. LOUIS , March 21, 2022  /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") announced today it has been awarded the Innovation Award for Health Equity by the National Committee for Quality Assurance (NCQA). The award recognizes Centene's data-driven Health Equity Improvement Model for being a leading-edge strategy for improving health equity and healthcare quality through innovative and creative solutions.

CENTENE RECOGNIZED WITH INNOVATION AWARD FOR HEALTH EQUITY

Goal-alignment and value-alignment has never been more critical for sports naming partnership rights. St. Louis CITY SC and Centene Corporation embody a strong alignment on goals, values, and shared corporate characteristics.

Sports Naming Rights Deals Based On Shared Values And Characteristics: The Case Of St. Louis CITY SC And Centene Corporation

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Centene (CNC) Down 3.6% Since Last Earnings Report: Can It Rebound?

Centene's (CNC) Indiana subsidiary receives a contract from the Indiana Department of Administration, thereby continuing to serve the unique health needs of Indiana communities.

Centene (CNC) Wins Contract to Serve Medicaid Members in Indiana

ST. LOUIS, March 9, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its Indiana subsidiary, Managed Health Services (MHS), has been selected by the Indiana Department of Administration to continue serving Hoosier Healthwise and Healthy Indiana Plan members with Medicaid and Medicaid alternative managed care and care coordination services. The new contract term is four years and includes the option for two, one-year renewals.

Centene Subsidiary Selected to Continue Serving Healthy Indiana Plan and Hoosier Healthwise Members

SACRAMENTO, Calif.--(BUSINESS WIRE)--Showing the promise of virtual care for Medi-Cal enrollees, a new survey of Medi-Cal providers released today by Health Net, one of California's longest-serving and most experienced Medi-Cal partners, reveals that telemedicine use increased from 2% of visits prior to the pandemic to 45% at the end of the first year of the pandemic, representing a more than 20x increase. “Health Net's unique grant program underscored telemedicine's ability to help bridge the

Telemedicine Visits at Key Medicaid Providers Increased by 2,000% during First Year of Pandemic, New Survey Finds

RANCHO CORDOVA, Calif., March 1, 2022 /PRNewswire/ -- Health Net Federal Services, LLC, (HNFS), a wholly-owned subsidiary of Centene Corporation (NYSE:CNC), announced today that its call center has been certified as a Center of Excellence by BenchmarkPortal for the tenth consecutive year.

Health Net Federal Services Earns Prestigious Center of Excellence Recognition from BenchmarkPortal for Tenth Consecutive Year

ST. LOUIS, Feb. 28, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Barclays Global Healthcare Conference, to be held Tuesday, March 15-Thursday, March 17, 2022, at the Loews Miami Beach Hotel. Centene will present on Tuesday, March 15 th at 9:00 a.m.

CENTENE TO PRESENT AT BARCLAYS GLOBAL HEALTHCARE CONFERENCE

Let's see if Centene Corporation (CNC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Should Value Investors Consider Centene (CNC) Stock Now?

Centene Corp said on Thursday its board had approved a request from its chairman and chief executive officer Michael Neidorff for a period of medical leave, effective immediately.

Centene CEO Michael Neidorff takes medical leave

Coupang

Mastercard

Microsoft

Oak Street Health

Visa

Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm's 13F portfolio changes for the fourth quarter of 2021, which ended on Dec. 31.

Lee Ainslie's Maverick Capital Is Buying Up Credit Card Stocks

ST. LOUIS, Feb. 24, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") announced today that its Board of Directors approved a request from Michael Neidorff, Chairman & Chief Executive Officer, for a medical leave of absence. James Dallas has been named Acting Chairman of the Board.

CENTENE ANNOUNCES APPROVAL OF REQUEST BY MICHAEL NEIDORFF, CHAIRMAN & CEO, TO TAKE A MEDICAL LEAVE OF ABSENCE

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net, one of California's longest serving and most experienced Medi-Cal partners, awarded a $150,000 grant to the UCSF California Preterm Birth Initiative (PTBi) and Cherished Futures for Black Moms & Babies (Cherished Futures). The organizations will use the funds to build a statewide coalition to advance Black birth justice. In the U.S., Black women are three times more likely to die from pregnancy-related causes than white women, and twice as li

Coalition of Black Birth Justice Leaders to Advance Health Equity for Black Californians, Funded by $150,000 Health Net Grant

Centene's (CNC) latest contract renewal tends to improve health outcomes of Medicaid members of Louisiana.

Centene (CNC) Boosts Presence in Louisiana With Contract Win

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net, one of California's longest serving and most experienced Medi-Cal partners, awarded more than $4.5 million to community-based nonprofits to help vaccinate communities hardest hit by COVID and increase vaccine equity. “After serving California's most vulnerable residents for more than four decades, we understand that healthcare is best delivered locally,” said Martha Santana-Chin, Medi-Cal President of Health Net. “When we set out to dispel myths

News for Centene Stock (CNC)